Kanvas Biosciences
Kanvas Biosciences57About
What does Kanvas Biosciences do?
Kanvas Biosciences builds microbial ecosystems for health using a full-stack technology platform for microbiome drug discovery. Their spatial mapping discovery engine visualizes host-microbiome interactions, enabling the development of scalable, clinical-stage therapies to precisely modulate host immunity. They serve patients by improving health outcomes through innovative microbiome-based treatments.
What is Kanvas Biosciences's revenue?
StartupHub estimates Kanvas Biosciences's annual revenue at $6.3M (range $3.4M to $17.4M, 68% confidence), based on comparable companies in the sector.
What is Kanvas Biosciences's valuation?
StartupHub estimates Kanvas Biosciences's effective valuation at $230.5M (range $145.0M to $348.0M, 23% confidence), based on comparable companies in the sector.
How much funding has Kanvas Biosciences raised?
Kanvas Biosciences has raised a total of $58M in funding. The most recent round on record is Funding Round.
Where is Kanvas Biosciences headquartered?
Kanvas Biosciences is headquartered in Princeton, New Jersey, USA.
When was Kanvas Biosciences founded?
Kanvas Biosciences was founded in 2021.
What industry does Kanvas Biosciences operate in?
Kanvas Biosciences operates in Biotechnology, Healthcare, Drug Discovery, Spatial Biology, Biotech, Clinical Trials.
How many employees does Kanvas Biosciences have?
Kanvas Biosciences has approximately 41 people on record.
No comments yet. Be the first to share your take.